Drugs / Lidocaine HCI
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT04383236 Comparator | Dec 2016 → Oct 2018 | aphthous stomatitis | Reham Lotfy Aggour | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lidocaine HCI | “Each 100 g contains: Lidocaine HCI 2.0g. Cetylpyridinium chloride 0.1 g.” NCT04383236 ↗ |
| Route | Topical | “For control subgroups, oracure gel were consecutively applied twice daily, for five days.” NCT04383236 ↗ |